We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

88 hedge funds and large institutions have $45.5M invested in G1 Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 17 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 17

43% more call options, than puts

Call options by funds: $8.85M | Put options by funds: $6.18M

2% more funds holding

Funds holding: 86 → 88 (+2)

8% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 24

26% less capital invested

Capital invested by funds: $61.6M → $45.5M (-$16.1M)

Holders
88
Holders Change
+2
Holders Change %
+2.33%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
33
Reduced
17
Closed
24
Calls
$8.85M
Puts
$6.18M
Net Calls
+$2.68M
Net Calls Change
+$210K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$9.21M
2
WP
Woodline Partners
California
+$5.2M
3
State Street
State Street
Massachusetts
+$2.55M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.19M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.89M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.63M
2
Millennium Management
Millennium Management
New York
-$1.93M
3
Bank of America
Bank of America
North Carolina
-$1.15M
4
Jane Street
Jane Street
New York
-$1.03M
5
Goldman Sachs
Goldman Sachs
New York
-$907K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$314K +$445K +116,405 +541%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$304K +$509K +133,230 New
Fidelity Investments
28
Fidelity Investments
Massachusetts
$296K +$266K +69,698 +116%
Man Group
29
Man Group
United Kingdom
$291K -$564K -147,635 -54%
FCA
30
FinTrust Capital Advisors
South Carolina
$230K – – –
ECM
31
ExodusPoint Capital Management
New York
$222K +$297K +77,833 +394%
UBS Group
32
UBS Group
Switzerland
$200K +$334K +87,329 +28,354%
FSA
33
Franklin Street Advisors
North Carolina
$190K – – –
BC
34
Birchview Capital
Vermont
$182K – – –
Bank of America
35
Bank of America
North Carolina
$179K -$1.15M -300,650 -79%
Dimensional Fund Advisors
36
Dimensional Fund Advisors
Texas
$171K -$10.3K -2,705 -3%
VF
37
Virtu Financial
New York
$170K +$284K +74,354 New
N
38
Nuveen
North Carolina
$153K +$256K +66,928 New
Jane Street
39
Jane Street
New York
$148K -$1.03M -268,656 -81%
GCM
40
Graham Capital Management
Connecticut
$126K +$137K +35,942 +186%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$115K +$190K +49,665 +5,136%
SG Americas Securities
42
SG Americas Securities
New York
$107K +$128K +33,588 +248%
AGM
43
Alpine Global Management
New York
$107K +$178K +46,728 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$101K +$170K +44,500 New
CFD
45
Creative Financial Designs
Indiana
$93K +$1.15K +300 +0.7%
BPA
46
Beacon Pointe Advisors
California
$90.5K -$15.3K -4,000 -9%
CL
47
Choreo LLC
Illinois
$87K – – –
RJFSA
48
Raymond James Financial Services Advisors
Florida
$84.3K +$21.3K +5,576 +18%
Invesco
49
Invesco
Georgia
$81.4K +$136K +35,709 New
Envestnet Asset Management
50
Envestnet Asset Management
Illinois
$80.5K -$466 -122 -0.3%
1
2
3 4 5

GTHX Hedge Fund Activity: Q2 2024 in Review

88 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q2 2024, worth a combined $45.5M — down 26% from $61.6M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new GTHX positions and 24 closed out — a net gain of 2 holders — while 33 added to existing stakes and 17 trimmed.

The largest buyer was BlackRock, adding an estimated $9.21M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $3.63M sold.

  • 88 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q2 2024, up from 86 in Q1 2024.
  • Funds reported $45.5M of G1 Therapeutics, Inc. Common Stock stock for Q2 2024, down 26% quarter-over-quarter.
  • 26 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q2 2024 and 24 closed out, a net change of +2 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q2 2024 was BlackRock, an estimated $9.21M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q2 2024 was Susquehanna International Group, an estimated $3.63M sold.

Based on aggregated 13F filings for Q2 2024.